earnings
JU
NASDAQ · JUNS
Jupiter Neurosciences, Inc.
Healthcare · Biotechnology
$2.93
Down-$0.08 (-2.66%)
Updated Sep 17, 2026, 12:15 PM
SID Score
4.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 41.02M
- P/E ratio
- -5.33
- Dividend yield
- 0.00%
- 52-week range
- $0.08 – $11.20
- Volume
- 22.09K
- Avg. volume
- 119.55K
Price performance
JUNS price history
1M range · 20 trading sessions · Daily adjusted prices
JUNS closed at $2.93 after 20 trading sessions, down 38.96% for the selected period.
- Last close
- $2.93
- Period change
- -38.96%
- Period low
- $2.93
- Period high
- $6.20
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $3.02 | $3.19 | $2.8801 | $2.93 | 22.09K |
| Sep 15, 2026 | $3.45 | $3.45 | $3.00 | $3.01 | 57.88K |
| Sep 14, 2026 | $3.12 | $3.5573 | $3.06 | $3.41 | 73.22K |
| Sep 11, 2026 | $3.17 | $3.20 | $3.00 | $3.05 | 21K |
| Sep 10, 2026 | $3.05 | $3.4064 | $3.05 | $3.15 | 42.89K |
| Sep 9, 2026 | $3.06 | $3.2377 | $2.9401 | $3.09 | 29.56K |
| Sep 8, 2026 | $3.20 | $3.28 | $3.06 | $3.08 | 41.05K |
| Sep 4, 2026 | $3.36 | $3.6091 | $3.27 | $3.28 | 25K |
| Sep 3, 2026 | $3.46 | $3.49 | $3.26 | $3.26 | 20.61K |
| Sep 2, 2026 | $3.35 | $3.5204 | $3.27 | $3.43 | 35.19K |
| Sep 1, 2026 | $3.39 | $3.57 | $3.22 | $3.35 | 60.23K |
| Aug 31, 2026 | $3.00 | $3.6499 | $2.88 | $3.54 | 261.26K |
| Aug 28, 2026 | $5.15 | $5.15 | $4.101 | $4.18 | 254.83K |
| Aug 27, 2026 | $4.94 | $5.00 | $4.711 | $4.89 | 87.84K |
| Aug 26, 2026 | $4.67 | $5.40 | $4.6209 | $5.01 | 224.61K |
| Aug 25, 2026 | $5.58 | $5.6916 | $4.93 | $5.17 | 228.52K |
| Aug 24, 2026 | $5.65 | $6.00 | $5.42 | $5.66 | 632.86K |
| Aug 21, 2026 | $8.25 | $11.20 | $5.50 | $6.20 | 52.41M |
| Aug 20, 2026 | $4.80 | $5.23 | $4.80 | $5.17 | 36.19K |
| Aug 19, 2026 | $4.94 | $5.0444 | $4.74 | $4.80 | 24.26K |
Latest JUNS news
The latest Smart Investors Daily articles mentioning JUNS.
Stock researchResearch & News · SEC Filings
Loading stock research…